HYPE: Folic acid before pregnancy reduces neural-tube defects.
But what does the evidence actually show?
Yes. Taking folic acid around conception reduces the risk of neural-tube defects such as spina bifida. It does not prevent every birth defect, and starting before pregnancy matters because the relevant development happens early.
What is the hype?
Some supplement claims promise an almost completely protected pregnancy, while others imply that food alone or an alternative folate form has identical prevention evidence. The reliable claim is narrower: folic acid at the appropriate time reduces a defined group of serious developmental defects.
The landmark trial tested recurrence
The MRC Vitamin Study randomised 1,817 women at high risk because of a previous affected pregnancy. Among 1,195 completed pregnancies with a known neural-tube outcome, there were six affected pregnancies in the folic-acid groups and 21 in the other groups—a 72% relative protective effect. This was a high-risk recurrence trial, not an estimate of the absolute benefit for every pregnancy. [1]
The systematic review supports prevention
A Cochrane review of five trials involving 7,391 women found a protective effect against neural-tube defects with folic acid around conception. It did not find clear evidence that the intervention prevents all other birth defects. The confidence in the specific neural-tube outcome should not be expanded into a blanket promise about healthy development. [2]
Current NHS advice makes timing practical
The NHS recommends 400 micrograms daily when trying to conceive, ideally beginning three months beforehand, and during the first 12 weeks of pregnancy. If pregnancy is discovered before supplementation has begun, the advice is to start as soon as possible. This is prevention guidance, not a claim that a missed dose determines an outcome. [3]
Some people need a different prescribed amount
NHS guidance identifies higher-risk situations in which a GP may prescribe 5 mg daily, including a previous neural-tube-affected pregnancy, relevant family history, diabetes and certain medicines or blood conditions. The appropriate amount should be established with a professional. More is not automatically better for everyone, and supplements do not replace routine antenatal care. [3]
The catch: limitations and uncertainty
The trial evidence includes different risk groups and supplementation regimens, and the absolute benefit depends on starting risk. No preventive measure removes all neural-tube-defect risk. The review also found limited evidence for alternative supplementation schemes; a product's folate-related marketing should not be assumed to provide identical prevention evidence.
What this means for you
If planning pregnancy, follow current NHS folic-acid advice and check with your GP or midwife whether you need the standard or a prescribed higher amount. Check the units carefully: micrograms and milligrams are different. If already pregnant, start promptly and seek routine advice without assuming that starting later means harm has occurred. Choose pregnancy-appropriate supplements and avoid doubling several products unnecessarily.
A well-established preventive benefit for a specific outcome, with timing central to the effect.
Research & Sources
1. MRC Vitamin Study Research Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
Randomised recurrence-prevention trial; published abstract.
Read the original source ↗2. De-Regil et al. (2015). Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
Cochrane review; neural-tube defects versus other outcomes.
Read the original source ↗3. NHS. Pregnancy vitamins and supplements.
Current timing, standard amount and higher-risk guidance.
Read the original source ↗Evidence reviewed: October 2026
This targeted editorial review considered sources available in October 2026. It is not an exhaustive systematic review. Source access and indirect evidence are identified above. Evidence vs Hype provides education, not individual diagnosis or treatment. Original AI-generated featured artwork is conceptual and does not demonstrate a study result. No commercial product was selected or endorsed.